James Carbonara | Managing Partner-Hayden IR, Inc. |
Jennifer Simpson | Chief Executive Officer |
Sue Horvath | Chief Financial Officer |
Robin Garner | Craig-Hallum |
Tony Butler | Roth Capital |
Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to the Panbela Therapeutics First Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. After management's prepared remarks, there will be a question-and-answer session.